The extracellular matrix is a complex network of proteins and carbohydrates that surrounds and supports cells in all tissues. It is not just a passive scaffold but an active regulator of cell behavior, tissue architecture and organ function. Its main components include fibrous proteins such as collagens and elastin, adhesive glycoproteins such as fibronectin and laminins, and hydrated gels of proteoglycans and glycosaminoglycans. These elements assemble into tissue specific structures that provide mechanical strength, elasticity and defined environments for cells.

Research shows that cells constantly sense and remodel their extracellular matrix through adhesion receptors such as integrins. Mechanical properties like stiffness and viscoelasticity strongly influence cell fate, migration and differentiation, helping to guide development and tissue repair. Altered matrix composition or mechanics contribute to many diseases, including fibrosis, cancer and cardiovascular disorders. In tumors, for example, matrix stiffening and reorganization can promote invasion and resistance to therapy.

The matrix also acts as a reservoir and modulator of signaling molecules, binding growth factors and cytokines and controlling their availability in space and time. This integration of biochemical and mechanical cues makes the extracellular matrix central to morphogenesis and homeostasis.

Current research uses advanced imaging, biophysical measurements and engineered matrices to map matrix structure and mechanics in living tissues. Synthetic and decellularized matrices are being developed to improve tissue engineering and regenerative medicine. By tuning matrix components and physical properties, scientists aim to better direct stem cell behavior and to design therapies that target pathological matrix remodeling in chronic disease and cancer.